9-(4'-dimethylaminophenyl)-2,6,7-trihydroxy-xanthene-3-one is a Potentially Novel Antiplatelet Drug which Antagonizes the Effect of Thromboxane A2

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|14|2|200-209

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.14, Iss.2, 2018-02, pp. : 200-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Novel Chemical Delivery System Comprising an Ocular Sustained Release Formulation of a 3α, 17α, 21-trihydroxy-5β-pregnan-20-one-BIS-5-Flourouracil Codrug

By Howard-Sparks Michelle   Al-Ghananeem Abeer M.   Crooks Peter A.   Pearson Andrew P.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 6, 2007-06 ,pp. : 677-682

Informa Healthcare

Access to resources Recommend Favorite

NEW INSIGHTS INTO THE PHARMACOLOGICAL PROPERTIES OF POTENT ANTIPLATELET 2-AMINO-BENZO[d]ISOTHIAZOL-3-ONE DERIVATIVES

By Ballabeni V.   Tognolini M.   Calcina F.   Impicciatore M.   Vicini P.   Barocelli E.  

Pharmacological Research, Vol. 46, Iss. 5, 2002-11 ,pp. : 389-393

Academic Press

Access to resources Recommend Favorite

Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist

By Tanaka T.   Fukuta Y.   Higashino R.   Sato R.   Nomura Y.   Fukuda Y.   Ito S.   Takei M.   Kurimoto T.   Tamaki H.  

European Journal of Pharmacology, Vol. 357, Iss. 1, 1998-09 ,pp. : 53-60

Elsevier

Access to resources Recommend Favorite

Antiplatelet Drugs - Do We Need New Options?: With a Reappraisal of Direct Thromboxane Inhibitors

By Coccheri Sergio  

Drugs, Vol. 70, Iss. 7, 2010-05 ,pp. : 887-908

Adis International

Access to resources Recommend Favorite

Which drug for hypertension and diabetes?

By  

Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite